1. Basic Information

Name:IGHE_HUMAN
Accession#:P01854
Description:Ig epsilon chain C region
AA Number:428
Sequence:
1
51
101
151
201
251
301
351
401
   ASTQSPSVFP LTRCCKNIPS NATSVTLGCL ATGYFPEPVM VTWDTGSLNG
TTMTLPATTL TLSGHYATIS LLTVSGAWAK QMFTCRVAHT PSSTDWVDNK
TFSVCSRDFT PPTVKILQSS CDGGGHFPPT IQLLCLVSGY TPGTINITWL
EDGQVMDVDL STASTTQEGE LASTQSELTL SQKHWLSDRT YTCQVTYQGH
TFEDSTKKCA DSNPRGVSAY LSRPSPFDLF IRKSPTITCL VVDLAPSKGT
VNLTWSRASG KPVNHSTRKE EKQRNGTLTV TSTLPVGTRD WIEGETYQCR
VTHPHLPRAL MRSTTKTSGP RAAPEVYAFA TPEWPGSRDK RTLACLIQNF
MPEDISVQWL HNEVQLPDAR HSTTQPRKTK GSGFFVFSRL EVTRAEWEQK
DEFICRAVHE AASPSQTVQR AVSVNPGK
*Highlighted peptides (with yellow background) have developed assays.
*Green background amino acids are PTMs.

2. Protein Separation

Sample Preparation: Human Serum from an IgE multiple myeloma patient was digested overnight with trypsin after reduction and alkylation with TCEP and IAA. Sample was then diluted 1:10 for analysis on a Thermo Scientific TSQ mass spectrometer

 

3. LC-MS/MS Data

GSGFFVFSR

    No LC-MS/MS for this peptide.

VAHTPSSTDWVDNK

    No LC-MS/MS for this peptide.

HWLSDR

    No LC-MS/MS for this peptide.

DFTPPTVK

    No LC-MS/MS for this peptide.

VTHPHLPR

    No LC-MS/MS for this peptide.

AAPEVYAFATPEWPGSR

    No LC-MS/MS for this peptide.

4. LC-MRM Screening

Peptides screening: Peptides and transitions for analysis were selected using SRM builder, a peptide predictive program. The results were screened for those with the highest specificity and the most intense transitions.